CLINICAL_TRIALS
trial_result
· 2025-12-03
Clinical Trial Update: A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension [Phase 2]
Summary
A Phase 2 trial evaluating treprostinil for interstitial lung disease-associated pulmonary hypertension has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Pulmonary Arterial Hypertension, Interstitial Lung Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-12-03